A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer

被引：0

作者：

Soukupova, Jana ^{[1
,2
]}

Stastna, Barbora ^{[1
,2
,3
,4
]}

Kanwal, Madiha ^{[3
]}

Hojny, Jan ^{[2
,5
]}

Zemankova, Petra ^{[1
,2
,6
]}

Borecka, Marianna ^{[1
,2
]}

Cerna, Leona ^{[7
]}

Cerna, Marta ^{[1
,2
]}

Cerna, Monika ^{[8
]}

Curtisova, Vaclava ^{[9
]}

Dolezalova, Tatana ^{[1
,2
]}

Duskova, Petra ^{[10
]}

Foretova, Lenka ^{[11
]}

Havranek, Ondrej ^{[2
,12
,13
]}

Horackova, Klara ^{[1
,2
]}

Hovhannisyan, Milena ^{[1
,2
]}

Hruskova, Lucie ^{[14
]}

Chvojka, Stepan ^{[7
]}

Janatova, Marketa ^{[1
,2
]}

Janikova, Maria ^{[9
]}

Jelinkova, Sandra ^{[1
,2
]}

Just, Pavel ^{[1
,2
]}

Kalousova, Marta ^{[1
,2
]}

Kleiblova, Petra ^{[1
,2
,12
]}

Kosarova, Marcela ^{[15
]}

Koudova, Monika ^{[7
]}

Kral, Jan ^{[1
,2
]}

Krausova, Michaela ^{[2
,5
]}

Krutilkova, Vera ^{[16
]}

Machackova, Eva ^{[11
]}

Matejkova, Katerina ^{[1
,2
,17
]}

Michalovska, Renata ^{[14
]}

Nehasil, Petr ^{[1
,2
,6
,18
]}

Nemcova, Barbora ^{[1
,2
]}

Novotny, Jan ^{[2
,12
,19
]}

Palek, Matous ^{[3
]}

Pesek, Pavel ^{[1
,2
]}

Safarikova, Marketa ^{[1
,2
]}

Scheinost, Ondrej ^{[10
]}

Springer, Drahomira ^{[1
,2
]}

Stolarova, Lenka ^{[3
]}

Stranecky, Viktor ^{[2
,18
]}

Subrt, Ivan ^{[8
]}

Tavandzis, Spiros ^{[16
]}

Tureckova, Eva ^{[1
,2
]}

Vesela, Kamila ^{[2
,12
]}

Vlckova, Zdenka ^{[14
]}

Vocka, Michal ^{[2
,20
]}

Zima, Tomas ^{[1
,2
]}

Macurek, Libor ^{[3
]}

机构：

[1] Charles Univ Prague, Inst Med Biochem & Lab Diagnost, Fac Med 1, Katerinska 32, Prague 12108, Czech Republic

[2] Gen Univ Hosp Prague, Katerinska 32, Prague 12108, Czech Republic

[3] Czech Acad Sci, Inst Mol Genet, Lab Canc Cell Biol, Videnska 1034, Prague 14220, Czech Republic

[4] Charles Univ Prague, Fac Sci, Dept Biochem, Prague, Czech Republic

[5] Charles Univ Prague, Inst Pathol, Fac Med 1, Prague, Czech Republic

[6] Charles Univ Prague, Inst Pathol Physiol, Fac Med 1, Prague, Czech Republic

[7] Ctr Med Genet & Reprod Med, GENNET, Prague, Czech Republic

[8] Univ Hosp Plzen, Inst Med Genet, Plzen, Czech Republic

[9] Palacky Univ, Univ Hosp Olomouc, Fac Med & Dent, Dept Med Genet, Olomouc, Czech Republic

[10] Hosp Ceske Budejovice, Ceske Budejovice, Czech Republic

[11] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic

[12] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic

[13] Charles Univ Prague, Fac Med 1, BIOCEV, Vestec, Czech Republic

[14] GHC Genet, Dept Med Genet, Prague, Czech Republic

[15] Pronatal, Dept Med Genet, Prague, Czech Republic

[16] AGEL Res & Training Inst, Dept Med Genet, AGEL Labs, Novy Jicin, Czech Republic

[17] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic

[18] Charles Univ Prague, Dept Paediat & Inherited Metab Disorders, Fac Med 1, Prague, Czech Republic

[19] Inst Clin & Expt Med, Prague, Czech Republic

[20] Charles Univ Prague, Fac Med 1, Dept Oncol, Prague, Czech Republic

来源：

CANCER MEDICINE | 2024年 / 13卷 / 16期

关键词：

breast cancer; Fanconi anemia complementation group G; functional analysis; germline genetic testing; hereditary tumors; ovarian cancer; ANEMIA; ASSOCIATION; REPAIR;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Monoallelic germline pathogenic variants (GPVs) in five Fanconi anemia (FA) genes (BRCA1/FANCS, BRCA2/FANCD1, PALB2/FANCN, BRIP1/FANCJ, and RAD51C/FANCO) confer an increased risk of breast (BC) and/or ovarian (OC) cancer, but the role of GPVs in 17 other FA genes remains unclear. Methods: Here, we investigated the association of germline variants in FANCG/XRCC9 with BC and OC risk. Results: The frequency of truncating GPVs in FANCG did not differ between BC (20/10,204; 0.20%) and OC (8/2966; 0.27%) patients compared to controls (6/3250; 0.18%). In addition, only one out of five tumor samples showed loss-of-heterozygosity of the wild-type FANCG allele. Finally, none of the nine functionally tested rare recurrent missense FANCG variants impaired DNA repair activities (FANCD2 monoubiquitination and FANCD2 foci formation) upon DNA damage, in contrast to all tested FANCG truncations. Conclusion: Our study suggests that heterozygous germline FANCG variants are unlikely to contribute to the development of BC or OC.

引用

页数：9

共 50 条

[21] Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast
Yadav, Siddhartha
Hu, Chunling
Nathanson, Katherine L.
Weitzel, Jeffrey N.
Goldgar, David E.
Kraft, Peter
Gnanaolivu, Rohan D.
Na, Jie
Huang, Hongyan
Boddicker, Nicholas J.
Larson, Nicole
Gao, Chi
Yao, Song
Weinberg, Clarice
Vachon, Celine M.
Trentham-Dietz, Amy
Taylor, Jack A.
Sandler, Dale R.
Patel, Alpa
Palmer, Julie R.
Olson, Janet E.
Neuhausen, Susan
Martinez, Elena
Lindstrom, Sara
Lacey, James V.
Kurian, Allison W.
John, Esther M.
Haiman, Christopher
Bernstein, Leslie
Auer, Paul W.
Anton-Culver, Hoda
Ambrosone, Christine B.
Karam, Rachid
Chao, Elizabeth
Yussuf, Amal
Pesaran, Tina
Dolinsky, Jill S.
Hart, Steven N.
LaDuca, Holly
Polley, Eric C.
Domchek, Susan M.
Couch, Fergus J.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (35) : 3918 - +
[22] Comprehensive Genomic Profiling to Examine Predisposition to Fluoropyrimidine Toxicity Caused by Germline DPYD Variants in Cancer Patients
Szelinger, S.
Aldrich, J.
Basu, G.
Evans, M.
Halbert, M.
Hall, D.
Hoag, J.
Thakkar, S.
Lobello, J.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S8 - S8
[23] Pathogenic germline variants in Mexican patients with hereditary breast and ovarian cancer syndrome
Vaca-Paniagua, Felipe
Quezada-Urban, Rosalia
Diaz-Velasquez, Clara
Gitler, Rina
Torres-Mejia, Gabriela
Rojo-Castillo, Maria Patricia
Sirota-Toporek, Max
Figueroa-Morales, Andrea
Moreno-Garcia, Oscar
Delgado-Enciso, Ivan
Garzon-Barrientos, Victor Hugo
Garcia-Esquivel, Nayeli Lizbeth
Rojas-Jimenez, Ernesto Arturo
Gregorio-Martinez, Hector
Terrazas, Luis Ignacio
CANCER RESEARCH, 2017, 77
[24] Myeloid neoplasms in individuals with breast and ovarian cancer and the association with deleterious germline variants
Franco, Stephanie
Godley, Lucy A.
GYNECOLOGIC ONCOLOGY, 2024, 187 : 235 - 240
[25] Spectrum of germline pathogenic variants in Brazilian hereditary breast/ovarian cancer cases
Faria, Joao Paulo
Assumpcao, Juliana Godoy
Matos, Lorena de Oliveira
Soardi, Fernanda Caroline
Bretz, Gabriel Pissolati Mattos
Friedman, Eitan
De Marco, Luiz
BREAST CANCER RESEARCH AND TREATMENT, 2024, 207 (03) : 615 - 624
[26] Germline variants in cancer predisposition genes in patients with uveal melanoma
Repo, Pauliina
Salminen, Eveliina
Jarvinen, Reetta-Stiina
Hiltunen, Juho
Al-Jamal, Rana'a
Tall, Martin
Raivio, Virpi
Kivela, Tero
Turunen, Joni
ACTA OPHTHALMOLOGICA, 2022, 100
[27] GERMLINE CANCER PREDISPOSITION VARIANTS ARE ASSOCIATED WITH SURVIVAL IN CHILDREN WITH RHABDOMYOSARCOMA
Lupo, Philip
Martin-Giacalone, Bailey
Casey, Dana
Li, He
Scheurer, Michael
Dugan-Perez, Shannon
Marquez-Do, Deborah
Muzny, Donna
Gibbs, Richard
Barkauskas, Donald
Hall, David
Stewart, Douglas
Schiffman, Joshua
Mcevoy, Matthew T.
Khan, Javed
Malkin, David
Skapek, Stephen
Venkatramani, Rajkumar
Hawkins, Douglas
Sabo, Aniko
Plon, Sharon
PEDIATRIC BLOOD & CANCER, 2022, 69
[28] Germline cancer predisposition variants and pediatric glioma: a population-based study in California
Muskens, Ivo S.
de Smith, Adam J.
Zhang, Chenan
Hansen, Helen M.
Morimoto, Libby
Metayer, Catherine
Ma, Xiaomei
Walsh, Kyle M.
Wiemels, Joseph L.
NEURO-ONCOLOGY, 2020, 22 (06) : 864 - 874
[29] Increased incidence of pathogenic variants in ATM in the context of testing for breast and ovarian cancer predisposition
P. Macquere
S. Orazio
F. Bonnet
N. Jones
V. Bubien
J. Chiron
D. Lafon
E. Barouk-Simonet
J. Tinat
L. Venat-Bouvet
P. Gesta
M. Longy
N. Sevenet
Journal of Human Genetics, 2022, 67 : 339 - 345
[30] Increased incidence of pathogenic variants in ATM in the context of testing for breast and ovarian cancer predisposition
Macquere, P.
Orazio, S.
Bonnet, F.
Jones, N.
Bubien, V
Chiron, J.
Lafon, D.
Barouk-Simonet, E.
Tinat, J.
Venat-Bouvet, L.
Gesta, P.
Longy, M.
Sevenet, N.
JOURNAL OF HUMAN GENETICS, 2022, 67 (06) : 339 - 345

← 1 2 3 4 5 →